Elisha has over 25 years of drug development experience. Elisha spent the last 14 years at PPD where she was most recently Head of Development Operations. In this role, she had global accountability for a $3.5B clinical trial portfolio. Elisha also led the team who developed and executed a COVID-19 vaccine program, achieving first time in man to emergency use authorization in less than 11 months. Elisha is recognized for generating and implementing innovative, strategic solutions. She is a founding member of PPD Biotech and led the creation and implementation of an industry-leading Biotech operating model which resulted in improved project cycle times and significant business expansion. Before PPD, Elisha led the Infectious Disease and Biotech project management teams at Covance (now Labcorp Drug Development).
 

 

Back